Laronde is creating safer and effective 'Endless RNA' therapies
Chemical & Engineering News (C&EN) - 30-Aug-2021Raised $440m to advance e-RNA based medicine for a wide range of diseases
Join the club for FREE to access the whole archive and other member benefits.
Life sciences firm
We’re a leading life sciences firm that conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability.
Visit website: https://www.flagshippioneering.com/
Details last updated 30-Apr-2020
Raised $440m to advance e-RNA based medicine for a wide range of diseases
To support human clinical trial of novel encapsulated cell therapy for hemophilia A